BioCryst Pharmaceuticals | BCRX - Ordinary Share Capital


BioCryst Pharmaceuticals reported $213.06M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Chugai Pharma JPY 1.65B 8K Dec/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
DBV Technologies USD 136.82M 51.98K Sep/2025
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novavax USD 162.58M 106K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025